Follow by Email

Friday, September 30, 2011

Macklin Medical Mission - Cancer - The True Story

Macklin Medical Mission
Death Rate due to Cancer
The Real Story


Cancer has been a fact of life in all its forms ever since life began on planet earth and has been one of the major limiters of life in general and why so many died long before they turned 40. In some countries on this planet – remains true to this very day.

A Little History Lesson

1. Radiology
This cancer treatment such as it is actually started in 1896. Interestingly enough this “therapy” turned up ten years after the founding of the Macklin Medical Mission to China in 1886. The treatment was developed by Mr. Arnold Feldman PhD in biochemistry at the department of radiation at the Methodist Medical center at the general hospital in Peoria, Illinois where they experimented with the use of X-Rays to treat cancer. Their initial treatments dealt with skin cancer and from there moved deeper into the body with some horrific side effects from the high energy form of radiation. The abrasive nature of this form of treatment is legendary in all its forms and yet we raise billions of dollars for this hundred year old plus form of cancer treatment. The modern “adjunctive form” of this treatment radiation treatment is now called machine-readable information magnetic resonance imaging or MRI. And while is it is much touted as a cancer treatment, the exposure to the skull has a proven increase in the rate of cancer by 50 percent especially brain cancer. [Again we refer you to Wikipedia to read on the side effects of MRI treatment - “it is still possible to deal with some of the side effects of the MRI treatment” – nice!

2. Chemotherapy
This cancer therapy if you can call it that is a little newer. This era of cancer chemotherapy began in the 1940’s [seventy years ago] with the first use of nitrogen mustard and folic acid antagonist drugs. This highly abrasive cancer treatments based on chemical based drug therapies development has exploded since then into a multi-billion dollar industry. The “targeted therapy” revolution had arrived, but many of the principles and limitations of chemotherapy discovered by the early researchers back in the 1940’s during the war still apply. The use of chemicals is simply nauseating in all their many forms. It’s as effective then as is it is now – i.e. “not very” [This from Wikipedia in 2011]

3. Mortality Rate due to Cancer in Canada
Again a little history. As he set off on his “Marathon of Hope” in 1980, Canadian icon Terry Fox imagined what could happen if Canadians put their support behind cancer research. Since then, Canada has made great strides in cancer care. But unfortunately maybe we haven’t due to the misdirection of funds raised in Canada.
Cancer is still the leading cause of premature death in Canada. The rising number of Canadians diagnosed with cancer continues to put significant demands on health systems. After al these years, progress on preventing cancer and improving its management is still a somewhat unpredictable process, making it an ongoing health-care challenge for governments at home and abroad. This should no longer be the case.
The impact that cancer has on the lives of patients especially the young, their families, and the health-care system cannot begin to be overstated. The long-term emotional, physical, and psychological strain on individuals diagnosed with cancer—and their families—is as tragic as it is profound. Just about everyone in Canada has been touched by cancer in some way.
Even today, one in four Canadians will die of cancer, with a slightly higher risk among men than among women and tragically the highest risk being to the children. In 2009-10, an estimated 171,000 Canadians will be diagnosed and 75,300, roughly half will die of cancer — an increase of 4,600 newly diagnosed cases and 1,500 deaths from the year before.
We aren’t moving ahead we are moving backwards due to outdated technology and treatments are largely to blame. The treatment of cancer is an industry in Canada and the vested interests of many in it is also largely to blame considering the salaries and the perks and the “prizes” and the consultants. Yes we are moving backwards the children who should be living are dying because of it and because of a lack of vision.
The cost of cancer care also places a heavy burden on the health-care system. One estimate finds that over the next 30 years beginning in 2012, 2.4 million workers will get cancer and 872,000 will die from the disease. Meanwhile, cancer will cost the Canadian economy an estimated $177.5 billion in direct health-care costs, $199 billion in corporate profits, $250 billion in taxation revenues, and $543 billion in wage-based productivity.
Cancer continues to exact a huge toll on the lives of Canadians; the country must not lag behind its peer countries in its efforts to reduce the incidence and mortality of cancer.
Canada is not a leader – it is a follower and a far distant follower at that – we stand 12th in all the western counties – that is absolutely disgusting and says a lot about the medical fraternity in Canada. Try telling that to your family physician and watch his or her face – then tell that to parents of children as they watch their children die in their arms, as Sunnybrook, Toronto Sick Kids, Mount Sinai and on it goes – its is truly nauseating in the extreme.

Canada gets a “B-” grade and ranks 12th among 16 peer countries. (Recent data are not available for Belgium.) In 2004—the most recent year of published data for Canada—there were 169 deaths due to cancer per 100,000 population. That rate rose – yes rose to an estimated 166 deaths per 100,000 population in 2006-7. That is absolutely pathetic.
The top performer — Finland a fraction of the Canadian GDP — had 135 deaths per 100,000 due to cancer; while the worst performer — Denmark — had 199 people die of cancer for every 100,000 population.
The Canadian Cancer Society reported recently that cancer will continue to place an increasing burden on Canadian society. Although the cancer mortality rate has dropped, the number of new cancer cases and deaths attributed to cancer actually continues to rise steadily as the Canadian population grows and ages.
Although some of the risks that lead to some cancers are very well documented, other cancers (and their related risk factors – spread ) continue to be something of a mystery. Whatever the current state of research and general knowledge, Canadians need to make the link between behaviours — such as poor eating habits, weight control, inactivity, alcohol, and tobacco consumption — and cancer. Most importantly, they need to adjust their lifestyles to reduce risks.

Even more importantly, Canadians need to make the link between behaviours of those raising funds for cancer research and where all the money is going. After all these years as I have said before cancer research is an “industry onto itself with vested interests in staff and outdated machines and outdated treatments – all of this would collapse if a cure was actually found and proven in clinical trials.

At one time it was heresy to say the world was round or that blood flowed in the human body or that he sun was the center of the galaxy - well the cure for cancer has arrived and it arrived in April of 2011 and using “adepts” from T-Cells combined through translational therapy in the lab with white blood cells and given them the cancer “codex” – all cancer can be treated at what ever stage and yes “cured” – without side effects and without any invasive treatments and yes without surgery.

The Macklin Medical Mission – Children’s Oncology Group [COG] is just the first and will be the only center in Canada to bring this treatment to Canadians once the trials are finished and once it has been approved by the Federal Government of the United States and Canada.

To do that we need to raise $23 million to build the oncology center – and to put an end to all those outdated cancer treatments which belong in the Rue Morgue or Madame Toussaud’s Wax Museum. The center will take a few years but it will be well worth it. Just ask the children who are dying still by the thousands. Better still ask their parents.

In our next Blog we will list all those corporations in Canada who refuse to help and who are tied to the existing forms of cancer treatment through their executive networks.

When the Macklin Medical Mission does become a reality- remember you first heard about while blood translational cellular cancer therapy from us. The “me-too” syndrome will quickly become apparent to coin a phrase all too soon by those using radiology and chemotherapy – after all they have a huge monolithic industry to preserve and staff to maintain – as usual.

12th place eh! …. Its time to be first! For the children, I say those who are last shall be first- and those who are first at the money trough shall be last.

One last thing … while Canadian doctors will want to know about this treatment, they will be among the very the last to support this new treatment financially.

We, at the Macklin Medical Mission, the oldest medical mission in the world, ask for your financial assistance to support our expanding efforts in this exciting new and highly successful field of white blood cells combined with T-Cell oncology research supported by the Nancy-Griffon Foundation Inc of Canada.
So, donate, support and invest in our cancer research – save a life.

Thank you.


Eric J. Macklin B.Com., FICB, FCSI, FMA, UE
Macklin Medical Mission [Est 1886]
Chairman
The Nancy-Griffon Foundation Inc [Est 1975]
Canada

Saturday, September 24, 2011

Macklin Medical Mission - Children's Oncology Centre (COG)

Annual Death Rate of Children Dying from Cancer
1975 to 2010

Remember – Remission is not a cure

What are the most common types of childhood cancer?

Among the 12 major types of childhood cancers, leukemias (blood cell cancers) and cancers of the brain and central nervous system account for more than half of the new cases. About one-third of childhood cancers are leukemias. The most common type of leukemia in children is acute lymphoblastic leukemia. The most common solid tumors are brain tumors (e.g., gliomas and medulloblastomas), with other solid tumors (e.g., neuroblastomas, Wilms tumors, and sarcomas such as rhabdomyosarcoma and osteosarcoma) being less common.

How many children are diagnosed with cancer in Canada and the United States annually?

In the United States in 2007, approximately 10,400 children under age 15 were diagnosed with cancer and about 1,545 children will die from the disease (1). Although this makes cancer the leading cause of death by disease among U.S. children 1 to 14 years of age, cancer is still relatively rare in this age group. On average, 1 to 2 children develop the disease each year for every 10,000 children in the United States and Canada.

How have childhood cancer incidence and survival rates changed over the years?

Over the past 20 years, there has been some increase in the incidence of children diagnosed with all forms of invasive cancer, from 11.5 cases per 100,000 children in 1975 to 14.8 per 100,000 children in 2004 to 16.9 in 2011. During this same time, however, death rates declined dramatically and 5-year survival rates increased for most childhood cancers. For example, the 5-year survival rates for all childhood cancers combined increased from 58.1 percent in 1975–77 to 79.6 percent in 1996–2003 (2). This improvement in survival rates is due to significant advances in treatment, resulting in a cure or long-term remission for a substantial proportion of children with cancer with the use of chemo or radiology which unfortunately has a 25% chance of some form of recurring cancer which drops the over all survival rate to 51.8%.

Long-term trends in incidence for leukemias and brain tumors, the most common childhood cancers, show patterns that are somewhat different from the others. Incidence of childhood leukemias appeared to rise in the early 1980s, with rates increasing from 3.3 cases per 100,000 in 1975 to 4.6 cases per 100,000 in 1985. Rates in the succeeding years have shown no consistent upward or downward trend and have ranged from 3.7 to 4.9 cases per 100,000.

For childhood brain tumors, the overall incidence rose from 1975 through 2009, from 2.3 to 3.2 cases per 100,000 (2), with the greatest increase occurring only from 1983 through l986.

An article in the September 2, 1998, issue of the Journal of the National Cancer Institute suggests that the rise in incidence from 1983 through 1986 may not have represented a true increase in the number of cases, but may have reflected new forms of imaging equipment (magnetic resonance imaging or MRI) that enabled visualization of brain tumors that could not be easily visualized with older equipment (3). Other important developments during this time period included the changing classification of brain tumors, which resulted in tumors previously designated as “benign” being reclassified as “malignant,” and improvements in neurosurgical techniques for biopsying brain tumors. Regardless of the explanation for the increase in incidence that occurred from 1983 to 1986, childhood brain tumor incidence has been essentially stable since the mid-1980s.

A monograph based on data from the National Cancer Institute’s (NCI) Surveillance, Epidemiology, and End Results (SEER) Program was published in 1999 on U.S. trends in incidence, mortality, and survival rates of childhood cancers. This monograph, Cancer Incidence and Survival Among Children and Adolescents: United States SEER Program 1975–1995, is available at http://seer.cancer.gov/publications/childhood/ on the Internet. In 2006, SEER published another monograph, Cancer Epidemiology in Older Adolescents and Young Adults 15 to 29 Years of Age, Including SEER Incidence and Survival: 1975–2000. This monograph is the first to collect detailed information about cancer incidence and outcomes in adolescents and young adults (AYA). It provides population-based incidence, mortality, and survival data specific to cancers that occur in the AYA population, along with epidemiological data and risk factors for the development of age-specific cancers. This resource is available at http://seer.cancer.gov/publications/aya/ on the Internet. More recent cancer statistics for children ages 0–14 and 0–19 are available in sections 28 and 29 of the SEER Cancer Statistics Review, 1975–2004 at http://seer.cancer.gov/csr/1975_2004/ on the Internet.

What are the known or suspected causes of childhood cancer?

The causes of childhood cancers are largely unknown. [This is blatantly not true] But the cure for all cancers is known as of April 2011. So why not fund it and use it rather than simply watch more children die.

Environmental causes of childhood cancer have long been suspected by many scientists but have been difficult to pin down, partly because cancer in children is rare and because it is difficult to identify past exposure levels in children, particularly during potentially important periods such as pregnancy or even prior to conception. In addition, each of the distinctive types of childhood cancers develops differently—with a potentially wide variety of causes and a unique clinical course in terms of age, race, gender, and many other factors. Possible risk factors for specific childhood cancers are discussed in the SEER monograph mentioned above. It can be found at http://seer.cancer.gov/publications/childhood/ on the Internet.

A number of studies are examining suspected or possible risk factors for childhood cancers, including early-life exposures to infectious agents; parental, fetal, or childhood exposures to environmental toxins such as pesticides, solvents, or other household chemicals; parental occupational exposures to radiation or chemicals; parental medical conditions during pregnancy or before conception; maternal diet during pregnancy; early postnatal feeding patterns and diet; and maternal reproductive history

What have studies shown about the possible causes of childhood cancer?

For several decades, the NCI, a part of the National Institutes of Health (NIH), has supported national and international collaborations devoted to studying the causes of cancer in children. Key findings from this research include the following:
High levels of ionizing radiation from accidents or from radiotherapy have been linked with increased risk of some childhood cancers.

Children with cancer treated with chemotherapy and/or radiation therapy are at an increased risk of 25% for developing a second primary cancer. For example, certain types of chemotherapy, including alkylating agents or topoisomerase II inhibitors (e.g., epipodophyllotoxins), can and will cause an increased risk of leukemia. That is a terrible price for young children and their parents to pay. It just prolongs the process of “inhumanization”. But there is a cure for cancer now.

Recent research has shown that children with AIDS (acquired immunodeficiency syndrome), like adults with AIDS, have an increased risk of developing certain cancers, predominantly non-Hodgkin lymphoma and Kaposi sarcoma. These children also have an additional risk of developing leiomyosarcoma (a type of muscle cancer).

Certain genetic syndromes (e.g., Li-Fraumeni syndrome, neurofibromatosis, and Gorlin syndrome) have been linked to an increased risk of specific childhood cancers. Children with Down syndrome have an increased risk of developing leukemia.
Low levels of radiation exposure from indoor radon have not been significantly associated with childhood leukemias.
Ultrasound use during pregnancy has not been linked with childhood cancer in numerous large studies.
Residential magnetic field exposure from power lines has not been significantly associated with childhood leukemias.
Pesticides have been suspected to be involved in the development of certain forms of childhood cancer based on interview data. However, interview results have been inconsistent and have not yet been validated by physical evidence of pesticides in the child’s body or environment.
No consistent findings have been observed linking specific occupational exposures of parents to the development of childhood cancers.
Several studies have found no link between maternal cigarette smoking before pregnancy and childhood cancers, but increased risks have been related to the father’s smoking habits in studies in the United Kingdom and China.
Little evidence has been found to link specific viruses or other infectious agents to the development of most types of childhood cancers, though investigators worldwide are exploring the role of exposures of very young children to some common infectious agents that may protect children from, or put them at risk for, developing certain leukemias.
What research is NCI currently doing on childhood cancer?

The NCI is funding a large portfolio of studies (http://fundedresearch.cancer.gov/) looking at the causes of and the most effective treatments for childhood cancers. Ongoing investigations include:
Studies to identify causes of the cancers that develop in children: The Children’s Oncology Group (COG) (http://www.childrensoncologygroup.org) is evaluating potential risk factors for a variety of childhood cancers. Very large studies have been completed of childhood acute lymphoblastic leukemia, acute myeloid leukemia, non-Hodgkin lymphoma, primitive neuroectodermal tumors of the brain, astrocytoma, neuroblastoma, and germ cell tumors. One large study, the Childhood Cancer Survivor Study, is evaluating the risks of second cancers related to radiation therapy and chemotherapy received by survivors of childhood cancer as part of treatment for their primary cancer (see below).

COG has also established a Childhood Cancer Research Network that creates a national registry of children with cancer. This initiative builds upon the unique NCI-supported national clinical trials system for treating children with cancer.

Monitoring of U.S. and international trends in incidence and mortality rates for childhood cancers: By identifying places where high or low cancer rates occur, researchers can uncover patterns of cancer that provide important clues for further in-depth studies into the causes and control of cancer.

Studies to better understand the biology of childhood cancer, with the hope that this understanding will lead to new treatment approaches that target critical cellular processes required for cancer cell growth and survival: The Childhood Cancer Therapeutically Applicable Research to Generate Effective Treatments (TARGET) Initiative was established by the NCI and the Foundation for the National Institutes of Health to identify and validate therapeutic targets in childhood cancers. The first TARGET project focuses on targets for high-risk acute lymphoblastic leukemia and the second TARGET project focuses on neuroblastoma. More information about the TARGET Initiative can be found in the article “Initiative TARGETs Childhood Cancer” at http://www.cancer.gov/NCICancerBulletin/NCI_Cancer_Bulletin_112106 on the Internet.

The Fund Raising for Cancer Research is a $25 billion dollar a year Corporate Drug Culture

Preclinical studies (animal studies) of new agents to identify promising anticancer drugs that can be evaluated in clinical trials: The NCI-supported Pediatric Preclinical Testing Program (PPTP) systematically evaluates new drugs and substances using animal models (animals with a cancer similar to or the same as a cancer found in children) to find the drugs most likely to have significant anticancer effects in clinical trials. The program is based on a large amount of research showing that animal models imitate the effects of proven anticancer drugs and can be used to prospectively identify new drugs that are effective against childhood cancers in subsequent patient studies. More information about the PPTP is available at http://pptp.nchresearch.org/ on the Internet. Questions concerning the PPTP can be addressed to the PPTP Project Officer, Dr. Malcolm Smith (malcolm.smith@nih.gov).

Projects designed to improve the health status of survivors of childhood cancers: The NCI funds the Childhood Cancer Survivor Study (CCSS), a study coordinated by St. Jude Children’s Research Hospital. The CCSS has over 25 sites across the country at medical institutions with doctors specializing in long-term care for children and young adults. This study was created to gain new knowledge and to educate cancer survivors about the long-term effects of cancer and cancer treatment. Information about the study is available at http://ccss.stjude.org/ on the Internet.
Clinical trials to identify superior treatments for childhood cancers, thereby leading to improved survival rates for children with cancer: Each year about 4,000 children enter 1 of approximately 100 ongoing clinical trials sponsored by the NCI. The following groups are conducting these trials:

The COG, with support from the NCI, conducts clinical trials devoted exclusively to children and adolescents with cancer at more than 200 member institutions, including cancer centers of all major universities, teaching hospitals throughout the United States and Canada, and sites in Europe and Australia. COG was formed in 2000 by the merger of four children’s cancer cooperative groups to accelerate the search for a cure for childhood cancers and to make it possible for children with cancer, regardless of where they live, to have access to state-of-the-art therapies and the collective expertise of world-renowned pediatric specialists.

The Pediatric Brain Tumor Consortium (PBTC) (http://www.pbtc.org) includes 10 leading academic institutions with extensive experience in the design and conduct of clinical trials for children with brain tumors. The group’s primary objective is to rapidly conduct phase I and II clinical evaluations of new therapeutic drugs, treatment delivery technologies, new biological therapies, and radiation treatment strategies in children up to age 21 with primary central nervous system (CNS) tumors. Another objective of the PBTC is to develop and coordinate innovative neuroimaging techniques. Results from PBTC studies are made available to large international collaborative groups for confirmatory phase II and multiagent phase III clinical trials.

New Approaches to Neuroblastoma Therapy (NANT) (http://www.nant.org) is a consortium of university and children’s hospitals funded by the NCI to test promising new therapies for neuroblastoma. NANT members constitute a group of closely collaborating investigators linked with laboratory programs where novel therapies for high-risk neuroblastoma are being developed. The group conducts early clinical trials to test new drugs and new combinations of drugs so promising therapies can be tested nationally.

The Pediatric Oncology Branch (POB) (http://pediatrics.cancer.gov) of the NCI’s Center for Cancer Research conducts basic, preclinical, and clinical studies of childhood cancer at the NIH Clinical Center in Bethesda, MD. Basic studies include analyses of genetic and biological characteristics of childhood cancers, as well as the study of immune system interactions with these cancers and the effects of chemotherapy on the immune system. Preclinical studies by the POB identify new drugs and types of immunotherapy (treatment to boost the immune system’s ability to fight cancer), as well as agents to control infectious diseases that occur in childhood cancer patients. An active clinical trial program includes phase I and phase II studies of new agents to treat childhood cancers, with a focus on molecularly targeted therapy and immunotherapy, as well as bone marrow transplantation and the development of immunotoxins (antibodies linked to a toxic substance that bind to cancer cells and kill them) to treat childhood leukemia. The POB also develops and tests new treatments for tumors associated with genetic predisposition syndromes such as neurofibromatosis type 1 and multiple endocrine neoplasia.

Evaluations of new drugs that may be more effective against childhood cancers and that may have less toxicity for children: The COG Phase I/Pilot Consortium is a major component of the NCI’s pediatric drug development program. The primary objective of the consortium is to develop and implement pediatric phase I and pilot studies to promote the integration of advances in cancer biology and therapy into the treatment of childhood cancer. The consortium includes approximately 20 institutions that carefully monitor the drugs for toxicity and safety. After their initial evaluation for safety in children by the consortium, the agents and regimens can then be studied within the larger group of COG institutions to determine their role in the treatment of specific childhood cancers.

Summary: The Macklin Medical Mission – There is an answer

There isn’t a single mention here of the very new and highly successful clinical trials being run using “translational white blood cells” from the cancer patients own body for a non-drug non-chemical non-invasive based cancer treatment for the cure of all forms of paediatric cancers with the Children’s Oncology Center to be build and established at the Macklin Medical Mission [COG] once the clinical trials are finished and both Federal Approval and Federal matching funding is available.

The longer it takes, the longer we will watch and read about children dying in the arms of their parents.

We, at the Macklin Medical Mission, the oldest medical mission in the world, ask for your financial assistance to support our expanding efforts in this exciting new and highly successful field of white blood cells combined with T-Cell oncology research supported by the Nancy-Griffon Foundation Inc of Canada.
So, donate, support and invest in our cancer research – save a life.

Thank you.


Eric J. Macklin B.Com., FICB, FCSI, FMA, UE
Macklin Medical Mission [Est 1886]
Chairman
The Nancy-Griffon Foundation Inc
Canada

Thursday, September 8, 2011

Macklin Medical Mission - New Children's Cancer Treatment Center (COG)

Cancer Research & Treatment

“ What lies ahead in our powers to do,
Also lies ahead in our powers not to do. “ – Dr. Lionel A. Macklin
School of Medicine
Cody Medal 1927
University of Toronto

For this Blog on the Macklin Medical Mission and its efforts to raise the $23 million in funds for the new cellular treatment center, we would like to address a couple of issues relevant to all those about to be afflicted with cancer, those currently dealing with many of the various cancers and those who have been “cured” with either radiology and chemotherapy. For those in the last group, they have according to 2011 statistics a 25% chance of a recurring form of cancer simply due to the extremely abrasive and toxic nature of radiology and chemotherapy.

The time has most definitely come to bring cancer research not only into the 21st century but to focus on the end game of cancer research itself. It’s not that we are researching the cure for specific cancers but for the cancer cell itself. I think we can all agree to that simple fact.

But the simple fact is that so many who are involved in either raising funds for cancer research per say or in doing cancer research into a specific affliction of cancer is that it is for the most part emotionally driven. Let me put it this way. Someone dies, which is usually the case, of say lung cancer, or breast cancer, or ovarian cancer, or prostate cancer and off they go to start a foundation to raise funds for that particular form of cancer and in so doing lose sight of the fact that cancer is cancer.

The amount of money raised by all these groups in fighting cancer for their chosen field of endeavour is gargantuan – for North America along is amounts to $3.5 billion dollars from both the private and public sector including of course Government funding. So there we have it $3.5 billion and growing. Of that amount almost 80% is spent on fund raising activities including prizes and the outrageous some of money for staff and doctors and nurses and councillors. In other words it is an industry onto itself. It promises much and delivers little in terms of the success ratio of the living and the dying.

To prove a point again, I refer you to the National Cancer Research Council on statistics in England, the United States and Canada. It is practically the same the world over. To date, and at best folks with cancer can expect an approximate survival rate of about 60% on a combined basis of all cancers. With radiology and chemotherapy this 60% has a 25% chance of remission, as I have said due in large part to the abrasive and harsh reality that it delivers to the autoimmune system of the body. Terrific. So that reduces the 60% to – let see 60 minus 25% … that’s only 45%.

After all these years and $3.5 in annual funding; who are we kidding other than ourselves and the kids for whom we treasure the most.

OK now, let us move into the 21st century.

We all now about vaccinations against the common cold right. Pretty simple stuff when you thing about it. Actually the common cold was not all that simple 50 years ago. People were dying by the 100’s of thousands. What we did was to develop a vaccine and have the annual vaccination of millions of folks starting with the most vulnerable, that’s right - the kids. The concept was developed in a small laboratory in a small Canadian town on shoe-string budget. Same story with antibiotics, another small laboratory; and again with the treatment of diabetes with insulin – Dr. Banting in a small laboratory in Alliston. Well known to Dr. Lionel Macklin. Along with Dr. Evan Shoute of London who developed vitamin E. All from the University of Toronto and all with small labs and all in small towns working back and forth with the University of Toronto. Also well known in the United States for their work.

So the next time you buy a few tickets to one of many well promoted cancer fund raising corporation like Sunnybrook for instance and think of the mansions in Oakville, that grand cottage and the fancy cars that require $20,000 in annual insurance fees to run should you be so lucky to win one – think of another laboratory that has not lost sight of the cancer cell itself. After all it is the necrosis of the cancer cell we all want. Charging off into the wild blue yonder for the cure of cancer this and cancer that is a waste of assets, funding and effort.

Back to thinking of vaccinations, and how it works, - we develop the strain we want to “cure” for the year and develop a vaccine, purify it and sell it buy the $100’s of millions to labs and governments around the world each year. Inject it into the shoulder muscle and then the white cells pick it up initially as an intruder then – bingo that “ah-ha moment” they interpret it for what it is and go charging off to kill that particular “spectrum of cold virus” in the body. Aren’t white cells neat.

OK – white cells, the army cells of the body. What if we find a cancer victim – that’s awfull, lets change that to “someone with cancer” – say breast cancer, lung cancer, ovarian cancer, brain cancer and withdraw some blood and run it through the ubiquitous centrifuge into red cells, white cells and plasma. Take some of the white cells and with T-cells “translate” a few of these “jacked cells” and re-inject them back into the same body they came out of. These translated cells have been given the “cancer cell interface” that they have never had before [vaccinated if you like] to use a computer term and go hunting for cancer cells. White cells may die in the process but lucky for the programme they multiply – just as God says “go ye forth and multiply”…. And bingo – cancer cell necrosis.

75% of the patients in the first group with stage four cancer had a complete 100% remission with the other 25% a 70% remission. Far in excess of the anticipated results including the growth in white blood cells. For those who were now cancer free these white blood cells now have the “cancer Codex” to kill again. It will never come back.

The clinic is now working with its second group of patients and the anticipated results will be better yet, including that 25% which may simply mean that they needed a second dosage.

If you are so lucky to find this Blog, and if we are so lucky in getting our $23 million in funding, you may be so lucky to find your cancer cure.

It is now up to you the tax payer, your company – another tax payer and its Board of Directors.

Cancer is no lottery ticket my friends, but then maybe we are wrong – buy a ticket instead – but remember this …..

“ What lies ahead in our powers to do,
Also lies ahead in our powers not to do. “

The longer it takes, the longer we will watch and read about children dying in the arms of their parents.

We, at the Macklin Medical Mission, the oldest medical mission in the world, ask for your financial assistance to support our expanding efforts in this exciting new and highly successful field of white blood cells combined with T-Cell oncology research supported by the Nancy-Griffon Foundation Inc of Canada.
So, donate, support and invest in our cancer research – save a life.

Thank you.

Eric J. Macklin B.Com., FICB, FCSI, FMA, UE
Macklin Medical Mission [Est 1886]
Chairman
The Nancy-Griffon Foundation Inc
Canada

Sunday, September 4, 2011

Macklin Medical Mission - New Children's Cancer Treatment

The Macklin Medical Mission
Center for Oncology Research and Treatment
Executive Summary

The Macklin Medical Mission is part of the Nancy-Griffon Foundation dedicated to the medical health and welfare of people. Over the years we have been involved in developing the funding and assistance for missions of medical specialists in the field of paediatrics and their staff and personnel around the world ever since the spring of 1885.

For the most part these team of specialist and generalist have been involved in reconstructive plastic surgery for the eyes, ears, nose and throat and in some cases rhinoplasty for cleft palates. Initially the latter came out of the work of many of our specialist as the result of war injuries, from the Crimean War to both the First and Second World Wars again specializing in injuries to the skull structure as well as those that evolved from birth defects later on.

From the early work led by Dr. William E. Macklin at the Nanking Medical Mission in Nanking China, later Nanjing up to the period of General Chiang Kai-Shek in the mid to late 1880’s to the late 1930’s to Dr. Alfred H. Macklin at the King George V hospital in Dublin Ireland. Both of these two famous Canadian doctors were later joined by Dr. Christine S. Macklin, one of the first women doctors to graduate from the University of Toronto and Dr. Daisy M. Macklin, both of who joined the Toronto Women’s Hospital. Dr. Bertrand Chapman’s work in New Delhi India was another medical mission supported by the Macklin Foundation.

Over the last 125 years Macklin doctors and their associates were joined by a host of other doctors to build medical missions around the world one of which became a medical college and later a medical school associated with the University of Nanjing graduating 8,000 doctors a year from a student body in excess of 50,000. The overall impact of these medical missions and teams over the last 125 years has been enormous.

Our primary mandate now is to raise funds to assist in the very new medical research both here and abroad and to build a medical clinic and training center here in Ontario, Canada dedicated to and to continue with the important work of Dr. Lionel A. Macklin who specialized in paediatric reconstructive surgery.

In terms of cancer research and treatment and with the very recent clinical successes in trials with translational therapy of white cells taken from the patients body conjoined and modified with stem cells, these "translational cells" were injected back into the body to become hunter killers of all cancer cells; the time has come to bring this into the field of paediatrics. The clinical studies have shown results far in advance of what was expected. As result 70% of cancer patients to date even with stage four cancer showed a total [100%] remission of all cancer cells and related tumours, and 30% with a 70% remission with one month. Clinical studies showed no side affects at all. Now is the time to end surgery, and ectomies.
Now is also the time to stop the very olde and out of date processes of radiology and chemotherapy which practically guarantee a 20% chance that cancer will return.

Our secondary focus, also non-invasive, for this new team at the Macklin Medical Mission will be in the new and fascinating field of non-invasive micro-nuclear laser oncology leading the eradication of cancer cell nuclei already formed within the body’s organs and to eliminate the growth of new cancer cells identified and mapped by spectrum based cellular dyes. To narrow our focus we will be dealing especially with those cancer cells within the pancreas, the liver, the prostate and uterine walls. The use of micro-nuclear laser in combination with cellular dyes which will have the ability to change colour based on the process of necrosis of the cancer cell from this treatment and the rate at which the laser destroys the nuclei of the cancer cell.

In this regards it will be necessary to develop spectral based lasers each with their own unique ability to penetrate deeper into the structural mass of the body’s larger internal organs. Currently this range of treatment is limited to slightly more than 1 inch or 2½ centimetres without having to dissect the organ itself. As a first step then we will specialize in paediatric research and care field for the applied application of micro-nuclear lasers and the organ tissue to be dealt which is smaller in infants and children.

Patients will be brought to the new Macklin Medical Mission clinic for treatment on three floors of the west wing with attending physicians and researchers and general offices on the three adjoining floors of the east wing. This new Macklin Medical Mission medical center will be built once we have reach our financial goal of raising $23 million in terms of funds raised and pledges made.

We sincerely hope that you, and many others like you, will join in with us in these two important and critical new fields of paediatric medicine in cancer research, and in the creation of the new Dr. Lionel A. Macklin clinic and research center. Thousands of children are dying each and every day from the ravages of cancer in its many and varied forms. We now have the answer. Lets use it.

Its time we hand a final death sentence to cancer cells the same sentence cancer cells have been handing to our children as long as mankind has walked this earth. Our children deserve a life free of the ravages of cancer to a beautiful life and free even of the threat of cancer. I am sure you will agree. You only have to visit a cancer clinic in a hospital and see parents in total horror watch as their children die in front of them to know that you can not stand by – so please say yes and help us help them.

· No more Radiology
· No more Chemotherapy
· No more Barium treatments
· No more surgery
· No more related side tissue damage
· Breast and Ovarian cancer as a major threat to women is history
· Prostate and Testicular cancer as a major threat to men is history
· The terror of chronic leukemia is history

While cancer will remain as an illness, it too like the common cold is history as we speak. With the Macklin Medical Mission we can bring this cancer treatment to one and all, both children and adults. Please help us, as we all know someone who is affected by this scourge, is dying or has died of cancer. While this has come to late for so many, we need to finish the job.

One final note and that is that both Radiology and Chemotherapy as a form of cancer treatment that the side-affects are so abrasive to the human body that these orwellian treatments are responsible for a 20% chance for all cancer survivors of experiencing a second form of cancer within one year after remission of the first cancer.

The longer it takes, the longer we will watch and read about children dying in the arms of their parents.

We, at the Macklin Medical Mission, the oldest medical mission in the world, ask for your financial assistance to support our expanding efforts in this exciting new and highly successful field of white blood cells combined with T-Cell oncology research supported by the Nancy-Griffon Foundation Inc of Canada.
So, donate, support and invest in our cancer research – save a life.

Thank you.

Eric J. Macklin B.Com., FICB, FCSI, FMA, UE
Macklin Medical Mission  [Est. 1886]
Chairman
The Nancy-Griffon Foundation [Est. 1976]
Canada
www.nancygriffonfund.com

Friday, September 2, 2011

Macklin Medical Mission - Childrens Oncology Center (COG)

The Macklin Medical Mission
Center for Oncology Research and Treatment
Executive Summary

The Macklin Medical Mission is part of the Nancy-Griffon Foundation dedicated to the medical health and welfare of people. Over the years we have been involved in developing the funding and assistance for missions of medical specialists in the field of paediatrics and their staff and personnel around the world ever since the spring of 1885.

For the most part these team of specialist and generalist have been involved in reconstructive plastic surgery for the eyes, ears, nose and throat and in some cases rhinoplasty for cleft palates. Initially the latter came out of the work of many of our specialist as the result of war injuries, from the Crimean War to both the First and Second World Wars again specializing in injuries to the skull structure as well as those that evolved from birth defects later on.

From the early work led by Dr. William E. Macklin at the Nanking Medical Mission in Nanking China, later Nanjing up to the period of General Chiang Kai-Shek in the mid to late 1880’s to the late 1930’s to Dr. Alfred H. Macklin at the King George V hospital in Dublin Ireland. Both of these two famous Canadian doctors were later joined by Dr. Christine S. Macklin, one of the first women doctors to graduate from the University of Toronto and Dr. Daisy M. Macklin, both of who joined the Toronto Women’s Hospital. Dr. Bertrand Chapman’s work in New Delhi India was another medical mission supported by the Macklin Foundation.

Over the last 125 years Macklin doctors and their associates were joined by a host of other doctors to build medical missions around the world one of which became a medical college and later a medical school associated with the University of Nanjing graduating 8,000 doctors a year from a student body in excess of 50,000. The overall impact of these medical missions and teams over the last 125 years has been enormous.

Our primary mandate now is to raise funds to assist in the very new medical research both here and abroad and to build a medical clinic and training center here in Ontario, Canada dedicated to and to continue with the important work of Dr. Lionel A. Macklin who specialized in paediatric reconstructive surgery.

In terms of cancer research and treatment and with the very recent clinical successes in trials with translational therapy of white cells taken from the patients body conjoined and modified with stem cells, these "translational cells" were injected back into the body to become hunter killers of all cancer cells; the time has come to bring this into the field of paediatrics. The clinical studies have shown results far in advance of what was expected. As result 70% of cancer patients to date even with stage four cancer showed a total [100%] remission of all cancer cells and related tumours, and 30% with a 70% remission with one month. Clinical studies showed no side affects at all. Now is the time to end surgery, and ectomies.
Now is also the time to stop the very olde and out of date processes of radiology and chemotherapy which practically guarantee a 20% chance that cancer will return.

Our secondary focus, also non-invasive, for this new team at the Macklin Medical Mission will be in the new and fascinating field of non-invasive micro-nuclear laser oncology leading the eradication of cancer cell nuclei already formed within the body’s organs and to eliminate the growth of new cancer cells identified and mapped by spectrum based cellular dyes. To narrow our focus we will be dealing especially with those cancer cells within the pancreas, the liver, the prostate and uterine walls. The use of micro-nuclear laser in combination with cellular dyes which will have the ability to change colour based on the process of necrosis of the cancer cell from this treatment and the rate at which the laser destroys the nuclei of the cancer cell.

In this regards it will be necessary to develop spectral based lasers each with their own unique ability to penetrate deeper into the structural mass of the body’s larger internal organs. Currently this range of treatment is limited to slightly more than 1 inch or 2½ centimetres without having to dissect the organ itself. As a first step then we will specialize in paediatric research and care field for the applied application of micro-nuclear lasers and the organ tissue to be dealt which is smaller in infants and children.

Patients will be brought to the new Macklin Medical Mission clinic for treatment on three floors of the west wing with attending physicians and researchers and general offices on the three adjoining floors of the east wing. This new Macklin Medical Mission medical center will be built once we have reach our financial goal of raising $23 million in terms of funds raised and pledges made.

We sincerely hope that you, and many others like you, will join in with us in these two important and critical new fields of paediatric medicine in cancer research, and in the creation of the new Dr. Lionel A. Macklin clinic and research center. Thousands of children are dying each and every day from the ravages of cancer in its many and varied forms. We now have the answer. Lets use it.

Its time we hand a final death sentence to cancer cells the same sentence cancer cells have been handing to our children as long as mankind has walked this earth. Our children deserve a life free of the ravages of cancer to a beautiful life and free even of the threat of cancer. I am sure you will agree. You only have to visit a cancer clinic in a hospital and see parents in total horror watch as their children die in front of them to know that you can not stand by – so please say yes and help us help them.

· No more Radiology
· No more Chemotherapy
· No more Barium treatments
· No more surgery
· No more related side tissue damage
· Breast and Ovarian cancer as a major threat to women is history
· Prostate and Testicular cancer as a major threat to men is history
· The terror of chronic leukemia is history

While cancer will remain as an illness, it too like the common cold is history as we speak. With the Macklin Medical Mission we can bring this cancer treatment to one and all, both children and adults. Please help us, as we all know someone who is affected by this scourge, is dying or has died of cancer. While this has come to late for so many, we need to finish the job.

One final note and that is that both Radiology and Chemotherapy as a form of cancer treatment that the side-affects are so abrasive to the human body that these orwellian treatments are responsible for a 20% chance for all cancer survivors of experiencing a second form of cancer within one year after remission of the first cancer.

The longer it takes, the longer we will watch and read about children dying in the arms of their parents.

We, at the Macklin Medical Mission, the oldest medical mission in the world, ask for your financial assistance to support our expanding efforts in this exciting new and highly successful field of white blood cells combined with T-Cell oncology research supported by the Nancy-Griffon Foundation Inc of Canada.
So, donate, support and invest in our cancer research – save a life.

Thank you.

Eric J. Macklin B.Com., FICB, FCSI, FMA, UE
Macklin Medical Mission [Est 1886]
Chairman
The Nancy-Griffon Foundation Inc
Canada